Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
France Banned AB Science Drug Studies Because of Side Effects
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
Newly diagnosed multiple sclerosis in state of Qatar.
Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod.
Preparation of Rat Oligodendrocyte Progenitor Cultures and Quantification of Oligodendrogenesis Using Dual-infrared Fluorescence Scanning.
Medication withdrawal in relapsing-remitting multiple sclerosis: why not?
Dual role of Response gene to complement-32 in multiple sclerosis.
Overview of the biology of type I interferons.
Suppression of Experimental Autoimmune Optic Neuritis by the Novel Agent Fingolimod.
The attributable burden of panic disorder in the impairment of quality of life in a national survey in Italy.
Right Under Our Noses: Olfactory Pathology In Central Nervous System Demyelinating Diseases
Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag.
Multiple sclerosis and pain.
Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic.
DMDs Are an Essential Issue But Are They the Only Issue in MS Treatment?
The spectrum of MOG autoantibody-associated demyelinating diseases.
The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study.
Biogen Idec to present new two-year data from the PLEGRIDY™ (peginterferon beta-1a) Phase III advance study at AAN annual meeting
Stelara (Ustekinumab) receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
160 Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis.
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis (EAE) Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge.
Reliability of a cognitive endpoint for use in a multiple sclerosis pharmaceutical trial.
Topographical and Biological Evidence Revealed FTY720-Mediated Anergy-Polarization of Mouse Bone Marrow-Derived Dendritic Cells In Vitro.
"Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.
Pages
« first
‹ previous
…
150
151
152
153
154
155
156
157
158
…
next ›
last »